Go Sekimoto

1.1k total citations
12 papers, 884 citations indexed

About

Go Sekimoto is a scholar working on Molecular Biology, Oncology and Clinical Psychology. According to data from OpenAlex, Go Sekimoto has authored 12 papers receiving a total of 884 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Oncology and 3 papers in Clinical Psychology. Recurrent topics in Go Sekimoto's work include TGF-β signaling in diseases (7 papers), Pancreatic and Hepatic Oncology Research (6 papers) and Palliative Care and End-of-Life Issues (3 papers). Go Sekimoto is often cited by papers focused on TGF-β signaling in diseases (7 papers), Pancreatic and Hepatic Oncology Research (6 papers) and Palliative Care and End-of-Life Issues (3 papers). Go Sekimoto collaborates with scholars based in Japan, Germany and United States. Go Sekimoto's co-authors include Katsunori Yoshida, Toshihito Seki, Kazuichi Okazaki, Koichi Matsuzaki, Miki Murata, Yoshiko Uemura, Jun–ichi Fujisawa, Noriko Sakaida, Mikio Nishizawa and Shigeo Mori and has published in prestigious journals such as Hepatology, Cancer Research and Oncogene.

In The Last Decade

Go Sekimoto

12 papers receiving 862 citations

Peers

Go Sekimoto
Comparison fields: 5 of 75
  • Molecular Biology 607
  • Oncology 386
  • Hepatology 258
  • Epidemiology 175
  • Pathology and Forensic Medicine 135
Replace Bijun Qiu with:
Bijun Qiu China
Jing‐Yun Wen China
Ye Jin Ha South Korea
Oxana V. Makarova‐Rusher United States
Qi‐Man Sun China
Yih-Jyh Lin Taiwan
Sedat Karademır Türkiye
Eleni Vrettou Greece
Rita Lepe United States
Maria Chiara Cantarini Italy
Bijun Qiu China View profile →
Citations per field, relative to Go Sekimoto
Go Sekimoto · 1×
Citations per year, relative to Go Sekimoto
Go Sekimoto · 1×

Countries citing papers authored by Go Sekimoto

Since Specialization
Citations

This map shows the geographic impact of Go Sekimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Go Sekimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Go Sekimoto more than expected).

Fields of papers citing papers by Go Sekimoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Go Sekimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Go Sekimoto. The network helps show where Go Sekimoto may publish in the future.

Co-authorship network of co-authors of Go Sekimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Go Sekimoto. A scholar is included among the top collaborators of Go Sekimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Go Sekimoto. Go Sekimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
# Work Indexed citations
1 1
2 1
3 5
4 16
5 113
6 141
7 2
8 3
9 120
10 245
11 81
12 156

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026